{"answer":{"query":"xarelto","resolved_as":"name","packages":23,"applications":["NDA022406","NDA215859"],"identity":{"application_numbers":["NDA022406","NDA215859"],"marketing_categories":["NDA"],"labelers":[{"text":"JANSSEN PHARMACEUTICALS, INC","untrusted":true}],"dosage_forms":[{"text":"GRANULE, FOR SUSPENSION","untrusted":true},{"text":"TABLET, FILM COATED","untrusted":true},{"text":"KIT","untrusted":true}],"marketing_start":{"earliest":"2011-07-01","latest":"2021-12-01","packages_with_a_start_date":17}},"price":{"median_negotiated_over_nadac":0.352,"packages_compared":19,"packages_listed":23,"negotiated_price_ends":"2026-12-31","rows":[{"ndc":"50458057501","name":{"text":"XARELTO ORAL SUSPENSION","untrusted":true},"class":"B","nadac_per_unit":3.76182,"negotiated_per_unit":1.329054,"ratio":0.353,"ful_per_unit":null},{"ndc":"50458057701","name":{"text":"XARELTO (rivaroxaban)","untrusted":true},"class":"B","nadac_per_unit":9.77539,"negotiated_per_unit":3.437073,"ratio":0.352,"ful_per_unit":3.678771},{"ndc":"50458057710","name":{"text":"XARELTO (rivaroxaban)","untrusted":true},"class":"B","nadac_per_unit":9.77539,"negotiated_per_unit":3.437073,"ratio":0.352,"ful_per_unit":3.678771},{"ndc":"50458057718","name":{"text":"XARELTO (rivaroxaban)","untrusted":true},"class":"B","nadac_per_unit":9.77539,"negotiated_per_unit":3.437073,"ratio":0.352,"ful_per_unit":3.678771},{"ndc":"50458057760","name":{"text":"XARELTO (rivaroxaban)","untrusted":true},"class":"B","nadac_per_unit":9.77539,"negotiated_per_unit":3.437073,"ratio":0.352,"ful_per_unit":3.678771},{"ndc":"50458057801","name":{"text":"XARELTO, 15MG TABLETS, HUD, 10 count BLISTER PACK (Inner NDC)","untrusted":true},"class":"B","nadac_per_unit":19.53423,"negotiated_per_unit":6.875115,"ratio":0.352,"ful_per_unit":null},{"ndc":"50458057810","name":{"text":"XARELTO (Rivaroxaban) Tablets 15mg, HUD (2x5) x 10, 6 count","untrusted":true},"class":"B","nadac_per_unit":19.53423,"negotiated_per_unit":6.875115,"ratio":0.352,"ful_per_unit":null},{"ndc":"50458057830","name":{"text":"XARELTO (Rivaroxaban) Tablets, 15mg, 30's, 24 count","untrusted":true},"class":"B","nadac_per_unit":19.53423,"negotiated_per_unit":6.875115,"ratio":0.352,"ful_per_unit":null},{"ndc":"50458057890","name":{"text":"XARELTO (Rivaroxaban) Tablets, 15mg, 90's, 24 count","untrusted":true},"class":"B","nadac_per_unit":19.53423,"negotiated_per_unit":6.875115,"ratio":0.352,"ful_per_unit":null},{"ndc":"50458057901","name":{"text":"XARELTO, 20MG TABLETS, HUD, 10 count BLISTER PACK (Inner NDC)","untrusted":true},"class":"B","nadac_per_unit":19.53935,"negotiated_per_unit":6.880894,"ratio":0.352,"ful_per_unit":null},{"ndc":"50458057910","name":{"text":"XARELTO (Rivaroxaban) Tablets 20mg, HUD (2x5) x 10, 6 count","untrusted":true},"class":"B","nadac_per_unit":19.53935,"negotiated_per_unit":6.880894,"ratio":0.352,"ful_per_unit":null},{"ndc":"50458057930","name":{"text":"XARELTO (Rivaroxaban) Tablets, 20mg, 30's, 24 count","untrusted":true},"class":"B","nadac_per_unit":19.53935,"negotiated_per_unit":6.880894,"ratio":0.352,"ful_per_unit":null},{"ndc":"50458057989","name":{"text":"XARELTO (Rivaroxaban) Tablets, 20mg, 1000's","untrusted":true},"class":"B","nadac_per_unit":19.53935,"negotiated_per_unit":6.880894,"ratio":0.352,"ful_per_unit":null},{"ndc":"50458057990","name":{"text":"XARELTO (Rivaroxaban) Tablets, 20mg, 90's, 24 count","untrusted":true},"class":"B","nadac_per_unit":19.53935,"negotiated_per_unit":6.880894,"ratio":0.352,"ful_per_unit":null},{"ndc":"50458058001","name":{"text":"XARELTO, 10MG TABLETS BLISTER PACK, HUD, 10 count BLISTER PACK","untrusted":true},"class":"B","nadac_per_unit":19.51936,"negotiated_per_unit":6.871878,"ratio":0.352,"ful_per_unit":null},{"ndc":"50458058010","name":{"text":"XARELTO 10MG HUD (2X5)X10","untrusted":true},"class":"B","nadac_per_unit":19.51936,"negotiated_per_unit":6.871878,"ratio":0.352,"ful_per_unit":null},{"ndc":"50458058030","name":{"text":"XARELTO 10MG 30S 24 COUNT","untrusted":true},"class":"B","nadac_per_unit":19.51936,"negotiated_per_unit":6.871878,"ratio":0.352,"ful_per_unit":null},{"ndc":"50458058090","name":{"text":"XARELTO 10MG 90S","untrusted":true},"class":"B","nadac_per_unit":19.51936,"negotiated_per_unit":6.871878,"ratio":0.352,"ful_per_unit":null},{"ndc":"50458058451","name":{"text":"Xarelto (Rivaroxaban) Starter Pack","untrusted":true},"class":"B","nadac_per_unit":19.47078,"negotiated_per_unit":6.852658,"ratio":0.352,"ful_per_unit":null},{"ndc":"55154142200","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"55154142308","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"55154142400","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null},{"ndc":"55154142408","name":{"text":"","untrusted":true},"class":null,"nadac_per_unit":null,"negotiated_per_unit":null,"ratio":null,"ful_per_unit":null}],"negotiated_scheduled":null},"generic_entry":[{"application":"NDA022406","date":"2034-08-17","reading":"upper bound from listed dates, not a forecast","basis":"latest of all listed patent and exclusivity expiries in this Orange Book edition; an upper bound from listed dates only, not a forecast of launch (litigation, settlements, delisting, tentative approvals and 180-day status are not modelled)","driver":{"kind":"patent","ref":"9539218*PED","productNo":"003"},"latest_patent_expiry":"2034-08-17","latest_exclusivity_expiry":"NOT_PROVIDED","dated_barriers":6,"undated_barriers":0,"orange_book_edition":"2026-09","patents_listed":1,"exclusivities_listed":0,"fact_id":"519f21a05580108badec090d"}],"label_history":{"events_total":37,"non_cmc_events":32,"counts_by_class":{"LABELING":26,"EFFICACY":6},"cmc_events":5,"recent_non_cmc_events":[{"application":"NDA022406","submission_no":45,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2026-03-24","documents":[{"type":"Label","date":"2026-03-26","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/022406s045lbl.pdf","untrusted":true}},{"type":"Letter","date":"2026-03-27","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/022406Orig1s045;215859Orig1s007ltr.pdf","untrusted":true}}],"fact_id":"8a3f251c050e3eb244bfc251"},{"application":"NDA215859","submission_no":7,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2026-03-24","documents":[{"type":"Label","date":"2026-03-27","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215859s007lbl.pdf","untrusted":true}},{"type":"Letter","date":"2026-03-27","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/022406Orig1s045;215859Orig1s007ltr.pdf","untrusted":true}}],"fact_id":"bed74224fdcd1f0d5141f0ca"},{"application":"NDA022406","submission_no":44,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2025-06-17","documents":[{"type":"Letter","date":"2025-06-18","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/022406Orig1s044;215859Orig1s005ltr.pdf","untrusted":true}},{"type":"Label","date":"2025-06-20","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022406s044,215859s005lbl.pdf","untrusted":true}}],"fact_id":"a4d00058ae478435579ca9e6"},{"application":"NDA215859","submission_no":5,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2025-06-17","documents":[{"type":"Letter","date":"2025-06-18","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/022406Orig1s044;215859Orig1s005ltr.pdf","untrusted":true}},{"type":"Label","date":"2025-06-20","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022406s044,215859s005lbl.pdf","untrusted":true}}],"fact_id":"d5f0a58c289a7e0c3dc76296"},{"application":"NDA022406","submission_no":41,"class_code":"LABELING","class_description":{"text":"Labeling","untrusted":true},"status":"AP","date":"2023-02-08","documents":[{"type":"Letter","date":"2023-02-09","link":{"text":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/022406Orig1s041;215859Orig1s002ltr.pdf","untrusted":true}},{"type":"Label","date":"2023-02-09","link":{"text":"http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022406s041lbl.pdf","untrusted":true}}],"fact_id":"ca33397630b897f066bee88d"}],"note":"a dated list of FDA supplements and their classes, not a reading of what changed in the label"},"substitution":{"products_total":5,"te_code_counts":{"AB":5},"marketing_status_counts":{"Prescription":4,"Discontinued":1},"meaning":"raw FDA codes; the therapeutic equivalence code says whether FDA rates a generic as substitutable, and what that means for a given prescription is for a pharmacist or prescriber","products":[{"application":"NDA022406","product_no":"003","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"XARELTO","untrusted":true},"form":{"text":"TABLET;ORAL","untrusted":true},"strength":{"text":"20MG","untrusted":true}},{"application":"NDA022406","product_no":"002","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"XARELTO","untrusted":true},"form":{"text":"TABLET;ORAL","untrusted":true},"strength":{"text":"15MG","untrusted":true}},{"application":"NDA022406","product_no":"001","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"XARELTO","untrusted":true},"form":{"text":"TABLET;ORAL","untrusted":true},"strength":{"text":"10MG","untrusted":true}},{"application":"NDA022406","product_no":"004","te_code":"AB","marketing_status":"Prescription","drug_name":{"text":"XARELTO","untrusted":true},"form":{"text":"TABLET;ORAL","untrusted":true},"strength":{"text":"2.5MG","untrusted":true}},{"application":"NDA215859","product_no":"001","te_code":"AB","marketing_status":"Discontinued","drug_name":{"text":"XARELTO","untrusted":true},"form":{"text":"FOR SUSPENSION;ORAL","untrusted":true},"strength":{"text":"1MG/ML","untrusted":true}}]},"supply":{"fda_shortage_status_counts":{"To Be Discontinued":1},"packages_with_a_termination_date":0,"next_package_termination_dates":[],"packages_with_future_termination_date":0,"termination_meaning":"manufacturer-reported last-lot expiry or withdrawal date of one package; other packages and generics can remain"},"trials":{"attribution":"Source: ClinicalTrials.gov","modification_statement":"OmniRx has summarized and trimmed this ClinicalTrials.gov data.","not_an_offer":"A recruiting trial listing is not an offer of free drug and not medical advice; enrollment is decided by the study team.","ingredients":[{"ingredient":{"text":"RIVAROXABAN","untrusted":true},"recruiting_interventional_count":67,"not_yet_recruiting_count":21,"by_phase":{"PHASE3":13,"NA":16,"PHASE4":30,"PHASE2":1,"EARLY_PHASE1":3,"PHASE1":2,"PHASE2/PHASE3":2},"registry_processing_date":"2026-11-06T10:00:05","modifications":"Counts and phase tallies computed here from the full recruiting result set; trials trimmed to the 25 most recently updated, conditions to 3, countries to 10 distinct; no text edited.","recent_trials":[{"nct_id":"NCT07318610","title":{"text":"Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease","untrusted":true},"phase":["PHASE3"],"sponsor":{"text":"Regeneron Pharmaceuticals","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-11-05","start_date":"2026-07-10","link":{"text":"https://clinicaltrials.gov/study/NCT07318610","untrusted":true}},{"nct_id":"NCT05701917","title":{"text":"DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis","untrusted":true},"phase":["NA"],"sponsor":{"text":"Inari Medical","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-11-03","start_date":"2023-01-06","link":{"text":"https://clinicaltrials.gov/study/NCT05701917","untrusted":true}},{"nct_id":"NCT07907211","title":{"text":"Aspirin vs. Rivaroxaban for Thromboprophylaxis in Multiple Myeloma","untrusted":true},"phase":["PHASE4"],"sponsor":{"text":"Chen Lijuan","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-10-30","start_date":"2024-02-01","link":{"text":"https://clinicaltrials.gov/study/NCT07907211","untrusted":true}},{"nct_id":"NCT06978439","title":{"text":"Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki Disease","untrusted":true},"phase":["PHASE4"],"sponsor":{"text":"Children's Hospital of Fudan University","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-10-22","start_date":"2024-01-10","link":{"text":"https://clinicaltrials.gov/study/NCT06978439","untrusted":true}},{"nct_id":"NCT06401616","title":{"text":"Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC)","untrusted":true},"phase":["PHASE4"],"sponsor":{"text":"Odense University Hospital","untrusted":true},"status":"RECRUITING","last_update_posted":"2026-10-21","start_date":"2024-05-21","link":{"text":"https://clinicaltrials.gov/study/NCT06401616","untrusted":true}}],"fact_id":"44bd7243485b0f388eae73e6"}]},"assistance_and_offers":{"programs_listing_this_drug":[{"name":{"text":"Johnson & Johnson Patient Assistance Program","untrusted":true},"type":"manufacturer","url":"https://www.jnjwithme.com/","status":null,"needs_status_check":false,"has_offer":false},{"name":{"text":"Bayer Patient Assistance Foundation","untrusted":true},"type":"manufacturer","url":"https://www.patientassistance.bayer.us/en/","status":null,"needs_status_check":false,"has_offer":false},{"name":{"text":"Janssen CarePath Savings for Xarelto","untrusted":true},"type":"manufacturer","url":"https://www.xarelto.com/cost-and-financial-support","status":null,"needs_status_check":false,"has_offer":false}],"manufacturer_offers":[{"program":"xarelto-copay-card","kind":"copay_card","price_figures":{"payAsLittleAsPerFill":10,"maxAnnualBenefit":3975},"conditions":{"text":"The page states the program is for patients with commercial or private insurance, that there are limits to savings per fill, and that savings may apply to co-pay, co-insurance or deductible.","untrusted":true},"limited_time":false,"expires_note":null,"stated_end_date":null,"expired":false,"detail":{"text":"The J&J withMe Xarelto page states pay as little as $10 per fill for patients with commercial or private insurance, with a maximum annual program benefit of $3,975 and limits to savings per fill. No end date is stated.","untrusted":true},"read_on":"2026-11-07T07:23:55.567Z","source_url":"https://www.jnjwithme.com/patient/xarelto/cost-support","proof_state":"verified","fact_id":"35b78b851e742e7103a59ae3"}],"note":"A program that lists a drug has not decided anything about any person: each program decides who qualifies, and a status other than open means it may not take new patients. Offers change and expire; read each offer's source and stated end date. A price figure is what the page states, not a quote."},"spending":{"reported_under":{"generic":{"text":"Rivaroxaban","untrusted":true},"brand":{"text":"Xarelto","untrusted":true}},"latest_year":2024,"series":[{"year":2020,"gross_spending_usd":4701314805,"claims":6491930,"beneficiaries":1184718,"average_spending_per_claim_usd":724.17829598,"fact_id":"fa26101a380ae94d466f35a0"},{"year":2021,"gross_spending_usd":5225547771.9,"claims":6458283,"beneficiaries":1258010,"average_spending_per_claim_usd":809.1233803,"fact_id":"3a53650bbc4fd30a7c051144"},{"year":2022,"gross_spending_usd":5772682547.9,"claims":6524784,"beneficiaries":1311333,"average_spending_per_claim_usd":884.73159386,"fact_id":"2b8646567c6fb4728d149c78"},{"year":2023,"gross_spending_usd":6309246822.6,"claims":6654162,"beneficiaries":1324165,"average_spending_per_claim_usd":948.16549741,"fact_id":"6683a30dd06a5e164f304401"},{"year":2024,"gross_spending_usd":6232231839.7,"claims":6660246,"beneficiaries":1321019,"average_spending_per_claim_usd":935.73598327,"fact_id":"c2a49875ecca00c3da750114"}],"rebate_caveat":"CMS's dataset states spending is gross drug cost and does not reflect manufacturers' rebates or other price concessions.","not_a_patient_price":"Spending is the total paid by Medicare, plans and beneficiaries for the drug's claims, not what a patient pays.","meaning":"a drug-level aggregate of Medicare Part D claims for all manufacturers combined; not a formulary, not coverage","source":{"dataset":{"text":"data-year-2024, modified 2026-06-25","untrusted":true},"link":{"text":"https://data.cms.gov/summary-statistics-on-use-and-payments/medicare-medicaid-spending-by-drug/medicare-part-d-spending-by-drug","untrusted":true}}},"medicaid_state_utilization":{"year":2025,"states_with_data":18,"all_states_medicaid_reimbursed_usd":1455730.61,"all_states_medicaid_paid_prescriptions":2295,"top_states":[{"state":"CA","medicaid_paid_prescriptions":245,"medicaid_reimbursed_usd":230829.19,"total_reimbursed_usd":231377.74,"packages":1,"covers":"fee_for_service_only","fact_id":"7d923165b1977fce4680122b"},{"state":"KY","medicaid_paid_prescriptions":429,"medicaid_reimbursed_usd":206013.1,"total_reimbursed_usd":206013.1,"packages":3,"covers":"fee_for_service_only","fact_id":"b466b20b0b109af4b51331be"},{"state":"OR","medicaid_paid_prescriptions":256,"medicaid_reimbursed_usd":146490.23,"total_reimbursed_usd":146490.23,"packages":2,"covers":"fee_for_service_only","fact_id":"616451371f6f53daac06ead0"},{"state":"HI","medicaid_paid_prescriptions":96,"medicaid_reimbursed_usd":120960.69,"total_reimbursed_usd":120960.69,"packages":1,"covers":"all_record_types","fact_id":"965a96a698cc50d61f3de7c2"},{"state":"UT","medicaid_paid_prescriptions":209,"medicaid_reimbursed_usd":119028.4,"total_reimbursed_usd":121084.36,"packages":1,"covers":"fee_for_service_only","fact_id":"db1a07b455c427fe9f860a3a"},{"state":"MN","medicaid_paid_prescriptions":77,"medicaid_reimbursed_usd":74629.97,"total_reimbursed_usd":74629.97,"packages":1,"covers":"fee_for_service_only","fact_id":"c092e20d13aee48b0afdd349"},{"state":"MI","medicaid_paid_prescriptions":77,"medicaid_reimbursed_usd":71892.82,"total_reimbursed_usd":71892.82,"packages":1,"covers":"fee_for_service_only","fact_id":"83dbc1ecd8dc2b3cbbbb8060"},{"state":"GA","medicaid_paid_prescriptions":145,"medicaid_reimbursed_usd":63945.59,"total_reimbursed_usd":69529.29,"packages":2,"covers":"fee_for_service_only","fact_id":"ba0061403f10598e2d4735bf"},{"state":"MD","medicaid_paid_prescriptions":69,"medicaid_reimbursed_usd":62519.93,"total_reimbursed_usd":63478.44,"packages":1,"covers":"fee_for_service_only","fact_id":"2703862bdd33723a580837b1"},{"state":"NV","medicaid_paid_prescriptions":151,"medicaid_reimbursed_usd":59364.6,"total_reimbursed_usd":65470.41,"packages":1,"covers":"all_record_types","fact_id":"c13cfb23ca54b655fe976e03"}],"unlabelled_state_code_xx":null,"built_from_facts":22,"facts_fee_for_service_only":14,"older_year_facts_not_used":428,"dataset":"State Drug Utilization Data 2025","read_on":"2026-11-07T22:41:44.201Z","reading":"Medicaid prescriptions and reimbursement by state (CMS State Drug Utilization Data). Reimbursement is before manufacturer rebates: not a net cost, not a patient price. Suppressed managed-care cells make a state figure fee-for-service only. An absent state was suppressed or unreported, not zero.","receipts_note":"a receipt is held for the largest fact behind each state shown; every figure is a sum of the built_from_facts facts, each recomputable from its recorded input hash"}},"receipts":[{"fact_id":"465d8283a929f446b857dd86","field":"ndc.listing","entity":"ndc:50458057501"},{"fact_id":"da0f77bd1f41df8f599d7398","field":"ndc.listing","entity":"ndc:50458057710"},{"fact_id":"112b4f7fa609df194f64de6d","field":"ndc.listing","entity":"ndc:50458057718"},{"fact_id":"7c17a11d3efcf1e07c34d2ee","field":"ndc.nadac_price","entity":"ndc:50458057501"},{"fact_id":"8c3624d579f9518356bdc94f","field":"ndc.nadac_price","entity":"ndc:50458057701"},{"fact_id":"7ba30107efe26d122ad75cc1","field":"ndc.nadac_price","entity":"ndc:50458057710"},{"fact_id":"8de0706c07f0919785941e71","field":"ndc.mfp","entity":"ndc:50458057501"},{"fact_id":"44d5dc2f1b180865bb7b8f1f","field":"ndc.mfp","entity":"ndc:50458057701"},{"fact_id":"a373920224a6640e5b92aa0c","field":"ndc.mfp","entity":"ndc:50458057710"},{"fact_id":"519f21a05580108badec090d","field":"drug.generic_entry_earliest","entity":"application:NDA022406"},{"fact_id":"ea6f87589775d95ed735534b","field":"drug.patent","entity":"application:NDA022406"},{"fact_id":"8a3f251c050e3eb244bfc251","field":"drug.label_event","entity":"application:NDA022406"},{"fact_id":"bed74224fdcd1f0d5141f0ca","field":"drug.label_event","entity":"application:NDA215859"},{"fact_id":"a4d00058ae478435579ca9e6","field":"drug.label_event","entity":"application:NDA022406"},{"fact_id":"d5f0a58c289a7e0c3dc76296","field":"drug.label_event","entity":"application:NDA215859"},{"fact_id":"ca33397630b897f066bee88d","field":"drug.label_event","entity":"application:NDA022406"},{"fact_id":"59091497c8726e5f5eeeb260","field":"drug.te_code","entity":"application:NDA022406"},{"fact_id":"e3edcc31f53dab8581a1886d","field":"drug.marketing_status","entity":"application:NDA022406"},{"fact_id":"5806a24ee30d33980d7dfeeb","field":"drug.te_code","entity":"application:NDA022406"},{"fact_id":"85af39b1bb89c6be5d69a863","field":"drug.marketing_status","entity":"application:NDA022406"},{"fact_id":"2f564fe0a56509cbb90df9cb","field":"drug.te_code","entity":"application:NDA022406"},{"fact_id":"88bad8085065982a5519af54","field":"drug.marketing_status","entity":"application:NDA022406"},{"fact_id":"2f2ef1b6b4984141ea92ff40","field":"drug.te_code","entity":"application:NDA022406"},{"fact_id":"37d2cf6e8e3e1c4343103f8c","field":"drug.marketing_status","entity":"application:NDA022406"},{"fact_id":"dae68be7106159bf34c7a1dd","field":"drug.te_code","entity":"application:NDA215859"},{"fact_id":"00545560c2ebf1f6ab402614","field":"drug.marketing_status","entity":"application:NDA215859"},{"fact_id":"df18ab784d92770b7d9a00f8","field":"ndc.shortage_row","entity":"ndc:50458057501"},{"fact_id":"44bd7243485b0f388eae73e6","field":"drug.trial_access","entity":"drug:rivaroxaban"},{"fact_id":"35b78b851e742e7103a59ae3","field":"program.offer","entity":"program:xarelto-copay-card"},{"fact_id":"fa26101a380ae94d466f35a0","field":"drug.partd_spending","entity":"drug:rivaroxaban|xarelto"},{"fact_id":"3a53650bbc4fd30a7c051144","field":"drug.partd_spending","entity":"drug:rivaroxaban|xarelto"},{"fact_id":"2b8646567c6fb4728d149c78","field":"drug.partd_spending","entity":"drug:rivaroxaban|xarelto"},{"fact_id":"6683a30dd06a5e164f304401","field":"drug.partd_spending","entity":"drug:rivaroxaban|xarelto"},{"fact_id":"c2a49875ecca00c3da750114","field":"drug.partd_spending","entity":"drug:rivaroxaban|xarelto"},{"fact_id":"7d923165b1977fce4680122b","field":"ndc.medicaid_state_utilization","entity":"ndc_state:50458057710:CA"},{"fact_id":"b466b20b0b109af4b51331be","field":"ndc.medicaid_state_utilization","entity":"ndc_state:50458057501:KY"},{"fact_id":"616451371f6f53daac06ead0","field":"ndc.medicaid_state_utilization","entity":"ndc_state:50458058090:OR"},{"fact_id":"965a96a698cc50d61f3de7c2","field":"ndc.medicaid_state_utilization","entity":"ndc_state:50458057989:HI"},{"fact_id":"db1a07b455c427fe9f860a3a","field":"ndc.medicaid_state_utilization","entity":"ndc_state:50458057830:UT"},{"fact_id":"c092e20d13aee48b0afdd349","field":"ndc.medicaid_state_utilization","entity":"ndc_state:50458058451:MN"},{"fact_id":"83dbc1ecd8dc2b3cbbbb8060","field":"ndc.medicaid_state_utilization","entity":"ndc_state:50458057501:MI"},{"fact_id":"ba0061403f10598e2d4735bf","field":"ndc.medicaid_state_utilization","entity":"ndc_state:50458057989:GA"},{"fact_id":"2703862bdd33723a580837b1","field":"ndc.medicaid_state_utilization","entity":"ndc_state:50458058451:MD"},{"fact_id":"c13cfb23ca54b655fe976e03","field":"ndc.medicaid_state_utilization","entity":"ndc_state:50458058090:NV"}],"as_of":{"newest_fact_retrieved_at":"2026-11-10T20:02:39.475Z"},"edition":{"id":"2026-11","merkleRoot":"006ab9a329709cbe7f56a0e1a7c4a02f897655cdfecf9ca34d199690095adcb6","factCount":212100,"manifestPresent":true},"licence":{"classes":["AMBER","GREEN"],"note":"Source records are public; this compilation is cited with attribution. See the provenance tool for each fact's licence label."},"unknown":[{"code":"NO_DATA","field":"generic_entry:NDA215859","reason":"no generic-entry fact for this application: no patent or exclusivity is listed for it in the Orange Book edition read, so no date is stated"},{"code":"NO_DATA","field":"recalls","reason":"no FDA enforcement report naming a package of these applications is recorded"},{"code":"NO_DATA","field":"policy","reason":"no Federal Register event in the edition names this drug or its programs"},{"code":"NO_DATA","field":"biologic_status","reason":"no biologic application of this drug has a Purple Book status in the edition (a drug that is not a biologic has none)"},{"code":"NO_DATA","field":"payment_limit","reason":"no HCPCS code whose NDC crosswalk names a package of these applications has a Part B payment limit in the edition"},{"code":"NO_DATA","field":"rems","reason":"no REMS@FDA program is tied to these applications in the edition (most drugs have none)"},{"code":"NO_DATA","field":"controlled_schedule","reason":"no DEA schedule entry matched this drug's ingredient in the edition"},{"code":"NO_DATA","field":"orphan_designation","reason":"no FDA orphan designation for this drug's ingredient is in the edition"},{"code":"NO_DATA","field":"safety_communication","reason":"no FDA Drug Safety Communication names this drug's ingredient in the edition"}],"disclaimer":"OmniRx is a reference layer of dated public facts, not clinical advice and not a guarantee of price, coverage or eligibility. Each answer lists the facts it rests on."}